Pulmonary Function and Survival 1 Year After Dupilumab Treatment of Acute Moderate to Severe Coronavirus Disease 2019: A Follow-up Study From a Phase 2a Trial.
Saved in:
| Title: | Pulmonary Function and Survival 1 Year After Dupilumab Treatment of Acute Moderate to Severe Coronavirus Disease 2019: A Follow-up Study From a Phase 2a Trial. |
|---|---|
| Authors: | Hendrick, Jennifer1 (AUTHOR), Ma, Jennie Z2 (AUTHOR), Haughey, Heather M3 (AUTHOR), Coleman, Rachael1 (AUTHOR), Nayak, Uma4 (AUTHOR), Kadl, Alexandra3,5 (AUTHOR), Sturek, Jeffrey M3 (AUTHOR), Jackson, Patrick1 (AUTHOR), Young, Mary K1 (AUTHOR), Allen, Judith E6 (AUTHOR), Petri, William A1,7,8 (AUTHOR) wap3g@uvahealth.org |
| Source: | Open Forum Infectious Diseases. Feb2024, Vol. 11 Issue 2, p1-9. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 23288957 |
|---|---|
| DOI: | 10.1093/ofid/ofad630 |
